Navigation Links
New Analyses of long-term LIALDA (mesalamine) data presented at ACG
Date:10/15/2007

percent (233/348) and 64.7 percent (66/102) of the patients with left-sided or extensive disease, respectively, were in remission at 12 months.

Post-hoc analysis of secondary endpoints of pivotal trials shows LIALDA offers initial resolution of UC symptoms within weeks

Also being presented at ACG are secondary endpoints from LIALDAs pivotal trials, the 301 and 302 studies, which were eight-week, phase III, placebo-controlled, double-blind, double-dummy studies.

Time to Initial Symptom Resolution with LIALDA for Active, Mild to Moderate Ulcerative Colitis
Poster Presentation: Monday, October 15, 2007, Exhibit Hall B, #619

An important endpoint for both patients and physicians when treating active, mild-to-moderate ulcerative colitis is the time between initiation of therapy and initial symptom resolution. A post-hoc analysis of pooled data from the LIALDA 301 and 302 studies examined the treatment time required for patients to experience initial symptom resolution of rectal bleeding and normalization of stool frequency. Patients with active, mild-to-moderate UC were randomized to receive LIALDA 2.4g/day (given once or twice daily) or 4.8g/day (given once daily) or placebo, for eight weeks. The time required for patients to reach an initial resolution of symptoms was analyzed and defined as the time between the first dose of medication and the first day of symptom resolution. A total of 517 patients were included. This post-hoc analysis showed median time to initial resolution of symptoms (stool frequency and rectal bleeding) was 25, 26 and 44 days, in the LIALDA 2.4g/day (n=172), 4.8g/day (n=174) and placebo (n=171) groups, respectively. The data in this post-hoc analysis included both stool frequency and rectal bleeding when determining the median time to initial resolution of symptoms.

Other posters to be presented at ACG include:

  • The effect of prolonged therapy with LIALDA in patients with ac
    '/>"/>

Contact: Ashleigh Duchene
aduchene@golinharris.com
312-729-4428
Shire plc
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Using Body Mass Index Skews Analyses on Obesity Rates
2. A New Study Analyses Benefits Of Statin Drug
3. UAE Analyses HIV Policies to Plan National Strategy
4. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
5. Long-Term Survival can be Predicted by a Simple Lung Test
6. Small lumps in breast if not treated may cause long-term harm
7. Lung Therapy Found To Have Long-Term Side Effects
8. Long-Term Benefits Of Statins Questioned
9. Long-term use of calcium supplements to prevent colon cancer
10. Survivors of childhood cancer may have long-term health problems
11. Long-term Care Should Be A Planned Affair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... La (PRWEB) March 06, 2015 Many ... function despite medical therapy. If you (or someone you ... to knee osteoarthritis, you may be interested in the ... Covington Orthopedic announced today that he is one of ... Cytori Therapeutics to begin enrolling subjects as part of ...
(Date:3/6/2015)... 06, 2015 Magellan Rx Management’s 2014 ... source for key trends and statistics on one of ... Executives from Magellan Rx Management will discuss key findings ... Your Hidden Specialty Drug Spend,” a complimentary March 19 ... , Specialty drug spend makes up more than a ...
(Date:3/6/2015)... March 06, 2015 Utilizing the latest ... rapidly reach their ideal weight has enabled Diet Doc ... to their already impressive collection of fat loss enhancement ... clients special promotions and savings to help people throughout ... This promotion is especially appealing to new clients ...
(Date:3/6/2015)... TX (PRWEB) March 06, 2015 Yisrayl ... in Abilene, Texas, has released a new publication explaining ... working. , The article titled “Microorganisms Do ... document explaining how tiny microorganisms were created and designed ... is aware of some of the functions of these ...
(Date:3/6/2015)... March 06, 2015 You Wealth ... created a unique ‘energy’ experiment to determine if ... , After quick ‘5 -7 minute’ remote ... 150+ countries reported their life improving - often ... positive results. , According to research, respondents saw ...
Breaking Medicine News(10 mins):Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 2Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 3Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 4Health News:Yisrayl Hawkins Tells Scientists Exactly What Makes Life Function Properly in New Publication 2Health News:250,000+ Person ‘Remote Energy’ Event has 94.2% of Respondents saying “Life Got Better” 2
... on Certain Products Expanded to Retail LevelST. LOUIS, Feb. 3 ... KVa ; KVb), is issuing a voluntary ... on certain products. The recall on the products listed ... is now being expanded to the retail level. The ...
... for Improving Cancer Care Access, Efficiency and Quality; ... NetworkWASHINGTON, Feb. 3 /PRNewswire-USNewswire/ -- The ... one of the nation,s largest cancer treatment and ... adopted its Principles for Reforming Cancer Care, designed ...
... 2009) Green tea products have become regarded as ... of its benefit against a variety of diseases, including ... green tea may counteract the anticancer effects of one ... be contraindicated for patients taking this medicine to ensure its ...
... to popular assumptions about the health benefits of green ... have found that the widely used supplement renders a ... cell lymphoma completely ineffective in treating cancer. , ... tea extract (GTE) called EGCG destroys any anticancer activity ...
... 3 VirtualScopics, Inc.,(Nasdaq: VSCP ), a ... that Mr. Jeff Markin, the company,s chief executive,officer, will ... Annual,BIO CEO & Investor Conference at the Waldorf Astoria ... Tuesday, February 10, 2009 at 3:45pm EST. , ...
... prescribed physical activity, survey finds, , , TUESDAY, Feb. 3 (HealthDay ... with and alleviate chronic neck and back pain, a new ... as often as they should. , Less than half ... had seen a physician, chiropractor or physical therapist in the ...
Cached Medicine News:Health News:ETHEX Corporation Issues Voluntary Nationwide Recall 2Health News:US Oncology Adopts Principles for Reforming Cancer Care 2Health News:US Oncology Adopts Principles for Reforming Cancer Care 3Health News:Green tea may negate the effects of a common cancer therapy 2Health News:Green tea may negate the effects of a common cancer therapy 3Health News:USC study finds that green tea blocks benefits of cancer drug 2Health News:VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference 2Health News:Are We Exercising Pain Away? Not So Much. 2
(Date:3/5/2015)... 5, 2015 BioLineRx (NASDAQ: ... dedicated to identifying, in-licensing and developing promising therapeutic ... underwritten public offering of American Depositary Shares ("ADSs"), ... All of the ADSs in the offering are ... JMP Securities is acting as sole book-running manager ...
(Date:3/5/2015)... Deutschland, 5. März 2015  Die amerikanische ... deutsche biopharmazeutische Unternehmen CureVac geben heute bekannt, ... Millionen US-Dollar) in CureVac investiert. CureVac ist ... Messenger-RNA (mRNA). Auf Basis dieses Moleküls entwickelt ... Krankheiten und zum Schutz vor Infektionskrankheiten. ...
(Date:3/5/2015)... March 5, 2015 CANTEL MEDICAL CORP. (NYSE: ... quarter ended January 31, 2015 on Thursday, March 12 before ... the results at 11:00 AM ET. To ... to 10 minutes before the beginning of the call. If ... call will be available from Thursday, March 12, 2015 through ...
Breaking Medicine Technology:BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2
... BEIJING , July 12 ... "Company") (NYSE: CCM ), the,operator of the largest ... today announced that effective as of July 1, 2010 ... for the operation of Chang,An,Hospital,s cancer treatment facilities by acquiring ...
... weeks beginning July 12 , ecoSTORE USA ,s elite team of Ecovisors will give ... select Duane Reade drug stores in New York City .  Ecovisors will also ... Nasty Ch e mic a l s™ ... , , ecoSTORE ...
Cached Medicine Technology:Concord Medical Enters into Joint Venture Agreement with Chang'An Hospital 2Concord Medical Enters into Joint Venture Agreement with Chang'An Hospital 3Concord Medical Enters into Joint Venture Agreement with Chang'An Hospital 4Ecovisors to Advise Duane Reade Shoppers 2Ecovisors to Advise Duane Reade Shoppers 3
... Pulsavac Wound Debridement System ... for pulsatile irrigation,and debridement. ... range of fluid pressure ... lavage to a penetrating ...
... Amsco 3085 SP Surgical Table provides state-of-the-art ... now be networked with the HERMES Control ... Stryker Endoscopy) to allow the surgeon direct ... surgeon uses either simple voice commands or ...
... The ASC 2000 is ... care table, meeting good manufacturing ... regulatory requirements. It provides electro-hydraulic ... accessories for all ambulatory surgical ...
... The hands play an important part ... traumatic impairments and rheumatic changes can cause ... developing of the finger-joint prostheses was to ... reproduce the natural function as nearly possible.,The ...
Medicine Products: